Investigating the response scale of the EORTC QLQ-C30 in German cancer patients and a population survey

被引:5
|
作者
Koller, Michael [1 ]
Mueller, Karolina [1 ]
Nolte, Sandra [2 ]
Schmidt, Heike [3 ,4 ,5 ]
Harvey, Christina [6 ]
Moelle, Ulrike [7 ]
Boehm, Andreas [7 ]
Engeler, Daniel [8 ]
Metzger, Juerg [9 ]
Sztankay, Monika [10 ,11 ]
Holzner, Bernhard [10 ,11 ]
Groenvold, Mogens [12 ]
Kulis, Dagmara [13 ]
Bottomley, Andrew [13 ]
机构
[1] Univ Hosp Regensburg, Ctr Clin Studies, D-93042 Regensburg, Germany
[2] Charite Univ Med Berlin, Div Psychosomat Med Berlin, Berlin, Germany
[3] Martin Luther Univ Halle Wittenberg, Inst Hlth & Nursing Sci, Halle, Saale, Germany
[4] Univ Hosp Halle Saale, Dept Radiat Med, Univ Clin, Halle, Saale, Germany
[5] Univ Hosp Halle Saale, Outpatient Clin Radiotherapy, Halle, Saale, Germany
[6] St Marienworth Hosp, Bad Kreuznach, Germany
[7] St Georg Hosp, Dept Otolaryngol Head & Neck Surg, Leipzig, Germany
[8] Cantonal Hosp St Gallen, Dept Urol, St Gallen, Switzerland
[9] Cantonal Hosp Lucerne, Dept Gen Surg, Luzern, Switzerland
[10] Med Univ Innsbruck, Dept Psychiat Psychotherapy & Psychosomat, Innsbruck, Austria
[11] Univ Hosp Psychiat II, Innsbruck, Austria
[12] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Geriatr & Palliat Med, Palliat Care Res Unit, Copenhagen, Denmark
[13] EORTC Headquarters, Qual Life Dept, Brussels, Belgium
关键词
Quality-of-life; Patient-reported outcomes; Response scales; Responder behaviour; Cognitive processes; QUALITY-OF-LIFE; VALIDATION; INSTRUMENT; DOMAINS;
D O I
10.1186/s12955-021-01866-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The European Organization for research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30) scales are scored on a 4-point response scale, ranging from not at all to very much. Previous studies have shown that the German translation of the response option quite a bit as massig violates interval scale assumptions, and that ziemlich is a more appropriate translation. The present studies investigated differences between the two questionnaire versions. Methods: The first study employed a balanced cross-over design and included 450 patients with different types of cancer from three German-speaking countries. The second study was a representative survey in Germany including 2033 respondents. The main analyses included compared the ziemlich and massig version of the questionnaire using analyses of covariance adjusted for sex, age, and health burden. Results: In accordance with our hypothesis, the adjusted summary score was lower in the massig than in the ziemlich version; Study 1: - 4.5 (95% CI - 7.8 to - 1.3), p = 0.006, Study 2: - 3.1 (95% CI - 4.6 to - 1.5), p < 0.001. In both studies, this effect was pronounced in respondents with a higher health burden; Study 1: - 6.8 (95% CI - 12.2 to - 1.4), p = 0.013; Study 2: - 4.5 (95% CI - 7.3 to - 1.7), p = 0.002. Conclusions: We found subtle but consistent differences between the two questionnaire versions. We recommend to use the optimized response option for the EORTC QLQ-C30 as well as for all other German modules.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population
    Pilz, Micha J.
    Loth, Fanny L. C.
    Nolte, Sandra
    Thurner, Anna M. M.
    Gamper, Eva-Maria
    Anota, Amelie
    Liegl, Gregor
    Giesinger, Johannes M.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [32] EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies
    Pamuk, Guelsuem Emel
    Harmandar, Ferda
    Ermantas, Nilay
    Harmandar, Orbay
    Turgut, Burhan
    Demir, Muzaffer
    Vural, Oezden
    ANNALS OF HEMATOLOGY, 2008, 87 (04) : 305 - 310
  • [33] Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
    Gamper, Eva M.
    Musoro, Jammbe Z.
    Coens, Corneel
    Stelmes, Jean-Jacques
    Falato, Claudette
    Groenvold, Mogens
    Velikova, Galina
    Cocks, Kim
    Flechtner, Hans-Henning
    King, Madeleine T.
    Bottomley, Andrew
    BMC CANCER, 2021, 21 (01)
  • [34] Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
    Maringwa, J.
    Quinten, C.
    King, M.
    Ringash, J.
    Osoba, D.
    Coens, C.
    Martinelli, F.
    Reeve, B. B.
    Gotay, C.
    Greimel, E.
    Flechtner, H.
    Cleeland, C. S.
    Schmucker-Von Koch, J.
    Weis, J.
    Van Den Bent, M. J.
    Stupp, R.
    Taphoorn, M. J.
    Bottomley, A.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2107 - 2112
  • [35] Validation of the Turkish Versions of EORTC QLQ-C30 and BR23 Modules in Breast Cancer Patients
    Demirci, Senem
    Eser, Erhan
    Ozsaran, Zeynep
    Tankisi, Deniz
    Aras, Arif B.
    Ozaydemir, Gul
    Anacak, Yavuz
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (05) : 1283 - 1287
  • [36] Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients
    Kim, Eun-ju
    Ko, Su-Kyoung
    Kang, Hye-Young
    QUALITY OF LIFE RESEARCH, 2012, 21 (07) : 1193 - 1203
  • [37] General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition
    Arraras, Juan Ignacio
    Nolte, Sandra
    Liegl, Gregor
    Rose, Matthias
    Manterola, Ana
    Illarramendi, Jose Juan
    Zarandona, Uxue
    Rico, Mikel
    Teiejria, Lucia
    Asin, Gemma
    Hernandez, Irene
    Barrado, Marta
    Vera, Ruth
    Efficace, Fabio
    Giesinger, Johannes M.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [38] Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer
    Mierzynska, Justyna
    Taye, Mekdes
    Pe, Madeline
    Coens, Corneel
    Martinelli, Francesca
    Pogoda, Katarzyna
    Velikova, Galina
    Bjelic-Radisic, Vesna
    Cardoso, Fatima
    Brain, Etienne
    Ignatiadis, Michail
    Piccart, Martine
    Van Tienhoven, Geertjan
    Mansel, Robert
    Wildiers, Hans
    Bottomley, Andrew
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 69 - 82
  • [39] Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
    Gray, Laura A.
    Hernandez Alava, Monica
    Wailoo, Allan J.
    BMC CANCER, 2021, 21 (01)
  • [40] Conceptual structure of the Taiwan Chinese version of the EORTC QLQ-C30
    Huang, Chi-Cheng
    Tu, Shih-Hsin
    Lien, Heng-Hui
    Huang, Ching-Shui
    Wang, Pa-Chun
    Chie, Wei-Chu
    QUALITY OF LIFE RESEARCH, 2015, 24 (08) : 1999 - 2013